<i>Plasmodium vivax</i>Malaria during Pregnancy, Bolivia

dc.contributor.authorLaurent Brutus
dc.contributor.authorJosé Santalla
dc.contributor.authorDominique Schneider
dc.contributor.authorJuan Carlos Avila
dc.contributor.authorPhilippe Deloron
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:11:04Z
dc.date.available2026-03-22T14:11:04Z
dc.date.issued2013
dc.descriptionCitaciones: 34
dc.description.abstractPlasmodium vivax is a major cause of illness in areas with low transmission of malaria in Latin America, Asia, and the Horn of Africa. However, pregnancy-associated malaria remains poorly characterized in such areas. Using a hospital-based survey of women giving birth and an antenatal survey, we assessed the prevalence rates of Plasmodium spp. infections in pregnant women in Bolivia, and evaluated the consequences of malaria during pregnancy on the health of mothers and newborns. P. vivax infection was detected in 7.9% of pregnant women attending antenatal visits, and placental infection occurred in 2.8% of deliveries; these rates did not vary with parity. Forty-two percent of all P. vivax malaria episodes were symptomatic. P. vivax-infected pregnant women were frequently anemic (6.5%) and delivered babies of reduced birthweight. P. vivax infections during pregnancy are clearly associated with serious adverse outcomes and should be considered in prevention strategies of pregnancy-associated malaria.
dc.identifier.doi10.3201/eid1910.130308
dc.identifier.urihttps://doi.org/10.3201/eid1910.130308
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45028
dc.language.isoen
dc.publisherCenters for Disease Control and Prevention
dc.relation.ispartofEmerging infectious diseases
dc.sourceDélégation Paris 5
dc.subjectMalaria
dc.subjectPlasmodium vivax
dc.subjectPregnancy
dc.subjectMedicine
dc.subjectObstetrics
dc.subjectTransmission (telecommunications)
dc.subjectPediatrics
dc.subjectPlasmodium falciparum
dc.title<i>Plasmodium vivax</i>Malaria during Pregnancy, Bolivia
dc.typearticle

Files